地中海贫血患者中去铁胺与地拉罗司联合治疗：对尿铁排泄的影响 - Suppr

Suppr

超能文献

Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion.

作者信息

Kattamis Antonis, Kassou Christina, Berdousi Helen, Ladis Vasilis, Papassotiriou Ioannis, Kattamis Christos

出版信息

Haematologica. 2003 Dec;88(12):1423-5.

PMID:14687998

Abstract

摘要

相似文献

Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion.

Haematologica. 2003 Dec;88(12):1423-5.

Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" beta-thalassemia major patients.

Am J Hematol. 2010 Jun;85(6):460-1. doi: 10.1002/ajh.21711.

Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with beta-thalassemia major.

Ann Hematol. 2004 Jul;83(7):471-3. doi: 10.1007/s00277-003-0820-0. Epub 2003 Dec 5.

Comparison of oral and subcutaneous iron chelation therapies in the prevention of major endocrinopathies in beta-thalassemia major patients.

Hemoglobin. 2006;30(2):257-62. doi: 10.1080/03630260600642609.

A randomized controlled study evaluating the safety and efficacy of deferiprone treatment in thalassemia major patients from Hong Kong.

Hemoglobin. 2006;30(2):263-74. doi: 10.1080/03630260600642617.

A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.

Circulation. 2007 Apr 10;115(14):1876-84. doi: 10.1161/CIRCULATIONAHA.106.648790. Epub 2007 Mar 19.

Timed non-transferrin bound iron determinations probe the origin of chelatable iron pools during deferiprone regimens and predict chelation response.

Haematologica. 2012 Jun;97(6):835-41. doi: 10.3324/haematol.2011.056317. Epub 2011 Dec 16.

Effects of combined deferiprone and deferoxamine chelation therapy on iron load indices in beta-thalassemia.

Hemoglobin. 2008;32(1-2):29-34. doi: 10.1080/03630260701680474.

Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience.

Ann Hematol. 2008 Jul;87(7):545-50. doi: 10.1007/s00277-008-0471-2. Epub 2008 Mar 20.

Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.

Blood Cells Mol Dis. 2009 May-Jun;42(3):247-51. doi: 10.1016/j.bcmd.2009.01.002. Epub 2009 Feb 23.

引用本文的文献

An evaluation of deferiprone as twice-a-day tablets or in combination therapy for the treatment of transfusional iron overload in thalassemia syndromes.

Expert Rev Hematol. 2023 Feb;16(2):81-94. doi: 10.1080/17474086.2023.2178409. Epub 2023 Feb 15.

A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer's and Parkinson's diseases.

Mol Divers. 2019 May;23(2):509-526. doi: 10.1007/s11030-018-9878-4. Epub 2018 Oct 6.

Deferasirox for managing iron overload in people with thalassaemia.

Cochrane Database Syst Rev. 2017 Aug 15;8(8):CD007476. doi: 10.1002/14651858.CD007476.pub3.

Deferasirox for managing iron overload in people with myelodysplastic syndrome.

Cochrane Database Syst Rev. 2014 Oct 28;2014(10):CD007461. doi: 10.1002/14651858.CD007461.pub3.

Deferasirox for managing transfusional iron overload in people with sickle cell disease.

Cochrane Database Syst Rev. 2014 Jun 4;5(5):CD007477. doi: 10.1002/14651858.CD007477.pub3.

Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion.

Rev Bras Hematol Hemoter. 2013;35(6):428-34. doi: 10.5581/1516-8484.20130106.

Oral deferiprone for iron chelation in people with thalassaemia.

Cochrane Database Syst Rev. 2013 Aug 21;2013(8):CD004839. doi: 10.1002/14651858.CD004839.pub3.

Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.

Cochrane Database Syst Rev. 2013 Aug 21;2013(8):CD004450. doi: 10.1002/14651858.CD004450.pub3.

Iron chelation therapy in thalassemia syndromes.

Mediterr J Hematol Infect Dis. 2009 Dec 29;1(1):e2009034. doi: 10.4084/MJHID.2009.034.

MRI evaluation of tissue iron burden in patients with beta-thalassaemia major.

Pediatr Radiol. 2007 Dec;37(12):1191-200; quiz 1308-9. doi: 10.1007/s00247-007-0567-1. Epub 2007 Aug 21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验